Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trial
- 5 February 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 41 (3) , 386-393
- https://doi.org/10.1016/s0735-1097(02)02767-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Defining the Optimal Activated Clotting Time During Percutaneous Coronary InterventionCirculation, 2001
- Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trialThe Lancet, 2000
- Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-IIThe Lancet, 1997
- Relation Between Activated Clotting Time During Angioplasty and Abrupt ClosureCirculation, 1996
- Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplastyJournal of the American College of Cardiology, 1994
- Is aggressive heparinization necessary for elective ptca?Catheterization and Cardiovascular Diagnosis, 1993
- The relationship of anticoagulation level and complications after successful percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1992
- Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinaseJournal of the American College of Cardiology, 1988
- Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapyThe American Journal of Medicine, 1987
- Heparin therapy during extracorporeal circulationThe Journal of Thoracic and Cardiovascular Surgery, 1975